EUVIMEDEUVIMED entdecken
Crossref

Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer

Silvia Bua, Alessio Nocentini iD, Alessandro Bonardi, Giuseppe Palma, Giulia Ciampi, Angela Giliberti, Federica Iannelli, Francesca Bruzzese, Claudiu T Supuran iD, Filomena de Nigris

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Silvia Bua und 9 weiteren Autor:innen. Beteiligte Einrichtung: NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, 50019 Sesto Fiorentino, Firenze Italy. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrase IX, Nitric Oxide, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe here the design and antitumor evaluation of benzofuroxan-based nitric oxide (NO)-donor hybrid derivatives targeting human carbonic anhydrases (hCAs) IX and XII. The most effective compounds, 27 and 28, demonstrated potent dual action, exhibiting low nanomolar inhibition constants against hCA IX and significant NO release. Notably, compound 27 showed significant antiproliferative effects against various cancer cell lines, particularly renal carcinoma A-498 cells. In these cells, it significantly reduced the expression of CA IX and iron-regulatory proteins, inducing apoptosis via mitochondrial caspase activity and ferroptosis pathways, as evidenced by increases in ROS, nitrite, and down-regulated expression of ferritin-encoding genes. In three-dimensional tumor models, compound 27 effectively reduced spheroid size and viability. In vivo toxicity studies in mice indicated that the compounds were well-tolerated, with no significant alterations in kidney function. These findings underscore the potential of benzofuroxan-based CA inhibitors for further preclinical evaluations as therapeutic agents targeting renal cell carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCarbonic Anhydrase IXNitric OxideAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorBenzoxazolesApoptosisCell ProliferationNitric Oxide DonorsAntigens, NeoplasmStructure-Activity RelationshipDrug Screening Assays, AntitumorOxadiazoles

Substanzen

Carbonic Anhydrase InhibitorsCarbonic Anhydrase IXNitric OxideAntineoplastic AgentsbenzofuroxanBenzoxazolesCA9 protein, humanNitric Oxide DonorsAntigens, NeoplasmOxadiazoles

Autor:innen und Institutionen

  • NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, 50019 Sesto Fiorentino, Firenze Italy.
  • Experimental Animal Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli 80131, Italy.
  • Department of Precision Medicine, School of Medicine, University of Campania "Luigi Vanvitelli″, Napoli 80138, Italy.
  • Experimental Pharmacology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione G. Pascale, Napoli 80131, Italy.

ORCID-Profile: Alessio Nocentini, Claudiu T Supuran

Zitieren

APA

Bua, S., Nocentini, A., Bonardi, A., Palma, G., Ciampi, G., Giliberti, A., Iannelli, F., Bruzzese, F., Supuran, C. T., & de Nigris, F. (2024). Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01563

Vancouver

Bua S, Nocentini A, Bonardi A, Palma G, Ciampi G, Giliberti A, et al. Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01563

BibTeX
@article{Bua2024,
  author = {Bua, Silvia and Nocentini, Alessio and Bonardi, Alessandro and Palma, Giuseppe and Ciampi, Giulia and Giliberti, Angela and Iannelli, Federica and Bruzzese, Francesca and Supuran, Claudiu T and de Nigris, Filomena},
  title = {Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01563}
}
Kostenlos starten →